ARCHIVES

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

This article is from The Cancer Letter archive.

Vol. 31 No. 6 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

ACS Picks Up Study Of tobacco Industry Influence On Voting By State Legislators

May 3, 1996

In Brief: Cooper Says HEW May Stop Taking New Construction grants; Cancer Act Does Not Give Him That Right

May 2, 1975

Regulatory Agencies: Health Warnings Sought on Cigars

July 23, 1999